TP53 and neuroblastoma: Prognosis is associated with a number of factors, including International Neuroblastoma Risk Group (INRG) stages, age at diagnosis, histopathological classification, the presence of segmental chromosomal alterations1,5, the activation of telomere maintenance mechanisms6,7 and somatic mutations in the RAS/MAPK and p53 pathway7.